Notably, RGD treatment reversed the elevated levels of FAK, SRC and AKT phosphorylation, as well as YAP expression, induced by VPS35 in GC cells through disrupting integrin-mediated outside-in signalling. This evidence concerns the gene PTK2 and gastric cancer.